Sage Mountain Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.47M | Buy |
5,732
+27
| +0.5% | +$21K | 0.29% | 44 |
|
|
2025
Q1 | $4.71M | Buy |
5,705
+271
| +5% | +$224K | 0.35% | 41 |
|
|
2024
Q4 | $4.19M | Buy |
5,434
+374
| +7% | +$289K | 0.31% | 45 |
|
|
2024
Q3 | $4.48M | Buy |
5,060
+198
| +4% | +$175K | 0.38% | 37 |
|
|
2024
Q2 | $4.4M | Buy |
4,862
+618
| +15% | +$559K | 0.41% | 35 |
|
|
2024
Q1 | $3.3M | Sell |
4,244
-195
| -4% | -$152K | 0.34% | 40 |
|
|
2023
Q4 | $2.59M | Buy |
4,439
+270
| +6% | +$157K | 0.3% | 49 |
|
|
2023
Q3 | $2.24M | Buy |
4,169
+206
| +5% | +$111K | 0.31% | 44 |
|
|
2023
Q2 | $1.86M | Sell |
3,963
-94
| -2% | -$44.1K | 0.26% | 51 |
|
|
2023
Q1 | $1.39M | Buy |
4,057
+2,393
| +144% | +$822K | 0.22% | 54 |
|
|
2022
Q4 | $609K | Buy |
1,664
+54
| +3% | +$19.8K | 0.14% | 60 |
|
|
2022
Q3 | $521K | Sell |
1,610
-104
| -6% | -$33.7K | 0.14% | 64 |
|
|
2022
Q2 | $556K | Sell |
1,714
-41
| -2% | -$13.3K | 0.1% | 201 |
|
|
2022
Q1 | $503K | Sell |
1,755
-16
| -0.9% | -$4.59K | 0.08% | 258 |
|
|
2021
Q4 | $489K | Buy |
1,771
+103
| +6% | +$28.4K | 0.06% | 311 |
|
|
2021
Q3 | $385K | Buy |
1,668
+423
| +34% | +$97.6K | 0.06% | 303 |
|
|
2021
Q2 | $286K | Buy |
1,245
+152
| +14% | +$34.9K | 0.05% | 323 |
|
|
2021
Q1 | $204K | Buy |
+1,093
| New | +$204K | 0.04% | 296 |
|